BRIEF-Supernus says Shire receives FDA approval for Mydayis for ADHD By: Reuters: Company News June 21, 2017 at 12:49 PM EDT * Supernus announces that its partner Shire receives FDA approval for Mydayis™ for ADHD Read More >> Related Stocks: Supernus Pharm